152.99 USD
+1.34 (+0.88%)
152.99 USD
0 (0%)
Overall ICUI gets a fundamental rating of 4 out of 10. We evaluated ICUI against 185 industry peers in the Health Care Equipment & Supplies industry. ICUI has an average financial health and profitability rating. ICUI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
ICUI had positive earnings in the past year.
In the past year ICUI had a positive cash flow from operations.
In multiple years ICUI reported negative net income over the last 5 years.
ICUI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of -0.18%, ICUI is doing good in the industry, outperforming 72.43% of the companies in the same industry.
The Return On Equity of ICUI (-0.35%) is better than 72.97% of its industry peers.
ICUI has a better Return On Invested Capital (2.86%) than 70.27% of its industry peers.
ICUI had an Average Return On Invested Capital over the past 3 years of 1.36%. This is significantly below the industry average of 8.84%.
The 3 year average ROIC (1.36%) for ICUI is below the current ROIC(2.86%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROIC | 2.86% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
1.3 Margins
With a decent Operating Margin value of 5.63%, ICUI is doing good in the industry, outperforming 70.27% of the companies in the same industry.
In the last couple of years the Operating Margin of ICUI has declined.
With a Gross Margin value of 36.47%, ICUI is not doing good in the industry: 70.81% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ICUI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% |
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
2. Health
2.1 Basic Checks
ICUI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ICUI has been increased compared to 1 year ago.
The number of shares outstanding for ICUI has been increased compared to 5 years ago.
ICUI has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.26 indicates that ICUI is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.26, ICUI is doing good in the industry, outperforming 62.70% of the companies in the same industry.
ICUI has a debt to FCF ratio of 21.21. This is a negative value and a sign of low solvency as ICUI would need 21.21 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 21.21, ICUI is in the better half of the industry, outperforming 69.73% of the companies in the same industry.
ICUI has a Debt/Equity ratio of 0.62. This is a neutral value indicating ICUI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.62, ICUI is not doing good in the industry: 63.24% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Altman-Z | 2.26 |
ROIC/WACC0.3
WACC9.67%
2.3 Liquidity
A Current Ratio of 2.45 indicates that ICUI has no problem at all paying its short term obligations.
ICUI has a Current ratio (2.45) which is comparable to the rest of the industry.
ICUI has a Quick Ratio of 1.19. This is a normal value and indicates that ICUI is financially healthy and should not expect problems in meeting its short term obligations.
ICUI has a Quick ratio of 1.19. This is in the lower half of the industry: ICUI underperforms 67.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
ICUI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.14%, which is quite impressive.
Measured over the past years, ICUI shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.28% on average per year.
The Revenue has decreased by -0.84% in the past year.
The Revenue has been growing by 13.47% on average over the past years. This is quite good.
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-8.85%
3.2 Future
Based on estimates for the next years, ICUI will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.56% on average per year.
Based on estimates for the next years, ICUI will show a small growth in Revenue. The Revenue will grow by 2.95% on average per year.
EPS Next Y23.92%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue Next Year-4.6%
Revenue Next 2Y-3.09%
Revenue Next 3Y-0.65%
Revenue Next 5Y2.95%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 19.22 indicates a rather expensive valuation of ICUI.
ICUI's Price/Earnings ratio is rather cheap when compared to the industry. ICUI is cheaper than 83.78% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.19, ICUI is valued a bit cheaper.
With a Price/Forward Earnings ratio of 18.65, ICUI is valued on the expensive side.
Based on the Price/Forward Earnings ratio, ICUI is valued cheaper than 83.78% of the companies in the same industry.
ICUI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.88, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.22 | ||
| Fwd PE | 18.65 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICUI indicates a rather cheap valuation: ICUI is cheaper than 83.78% of the companies listed in the same industry.
72.97% of the companies in the same industry are more expensive than ICUI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 60.69 | ||
| EV/EBITDA | 14.28 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ICUI's earnings are expected to grow with 14.98% in the coming years.
PEG (NY)0.8
PEG (5Y)N/A
EPS Next 2Y14.84%
EPS Next 3Y14.98%
5. Dividend
5.1 Amount
ICUI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
152.99
+1.34 (+0.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners118.03%
Inst Owner Change0%
Ins Owners0.96%
Ins Owner Change-1.93%
Market Cap3.78B
Revenue(TTM)2.32B
Net Income(TTM)-7.36M
Analysts83.33
Price Target185.03 (20.94%)
Short Float %5.49%
Short Ratio5.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.05%
Min EPS beat(2)37.25%
Max EPS beat(2)38.85%
EPS beat(4)4
Avg EPS beat(4)36.86%
Min EPS beat(4)31.74%
Max EPS beat(4)39.58%
EPS beat(8)8
Avg EPS beat(8)33.65%
EPS beat(12)12
Avg EPS beat(12)26.3%
EPS beat(16)15
Avg EPS beat(16)20.15%
Revenue beat(2)1
Avg Revenue beat(2)0.69%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)3.14%
Revenue beat(4)3
Avg Revenue beat(4)1.65%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.14%
Revenue beat(8)6
Avg Revenue beat(8)1.04%
Revenue beat(12)6
Avg Revenue beat(12)-0.86%
Revenue beat(16)8
Avg Revenue beat(16)-0.49%
PT rev (1m)0%
PT rev (3m)2.02%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.97%
EPS NY rev (1m)0%
EPS NY rev (3m)8.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.98%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.22 | ||
| Fwd PE | 18.65 | ||
| P/S | 1.63 | ||
| P/FCF | 60.69 | ||
| P/OCF | 23.69 | ||
| P/B | 1.78 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.28 |
EPS(TTM)7.96
EY5.2%
EPS(NY)8.2
Fwd EY5.36%
FCF(TTM)2.52
FCFY1.65%
OCF(TTM)6.46
OCFY4.22%
SpS93.98
BVpS86.16
TBVpS-1.47
PEG (NY)0.8
PEG (5Y)N/A
Graham Number124.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROCE | 3.62% | ||
| ROIC | 2.86% | ||
| ROICexc | 3.12% | ||
| ROICexgc | 9.01% | ||
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% | ||
| FCFM | 2.68% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexgc growth 3Y-18.09%
ROICexgc growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Debt/EBITDA | 3.95 | ||
| Cap/Depr | 47.91% | ||
| Cap/Sales | 4.19% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 47.79% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.26 |
F-Score7
WACC9.67%
ROIC/WACC0.3
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
EPS Next Y23.92%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-8.85%
Revenue Next Year-4.6%
Revenue Next 2Y-3.09%
Revenue Next 3Y-0.65%
Revenue Next 5Y2.95%
EBIT growth 1Y142.55%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year43.36%
EBIT Next 3Y18.75%
EBIT Next 5Y17.88%
FCF growth 1Y597.89%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y117.81%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%
ICU MEDICAL INC / ICUI FAQ
What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ICUI.
Can you provide the valuation status for ICU MEDICAL INC?
ChartMill assigns a valuation rating of 6 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.
What is the profitability of ICUI stock?
ICU MEDICAL INC (ICUI) has a profitability rating of 4 / 10.
Can you provide the financial health for ICUI stock?
The financial health rating of ICU MEDICAL INC (ICUI) is 4 / 10.
What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?
The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 23.92% in the next year.